NCT01858116View on ClinicalTrials.gov

PET Study of Breast Cancer Patients Using [68Ga]ABY-025

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Breast Cancer
Interventions
DRUG

[68Ga]ABY-025

Intravenous injection followed by PET imaging

Trial Locations (1)

SE-751 85

Uppsala University Hospital, Uppsala

Sponsors

Collaborators (1)

Affibody
All Listed Sponsors
collaborator

Swedish Cancer Society

OTHER

collaborator

Affibody

INDUSTRY

lead

Biomedical Radiation Sciences

OTHER